usdaed

Like Intel, a company recently demonstrating a belated recovery, ASML (ASML 2.79%) has attracted investor attention. This is not necessarily an indication of inherent value, but rather a predictable consequence of a market eager for narratives of renewal. ASML, it should be understood, is the sole manufacturer of extreme ultraviolet (EUV) lithography machines, the complex and expensive devices required for producing the most advanced semiconductor chips. The company sells a relatively small number – around one hundred per quarter – making its fortunes acutely sensitive to shifts in demand, a cycle that operates at a different tempo than the broader semiconductor market.

This treatise, the third and final act in our exploration of the Voyager Portfolio‘s potential acquisitions, shall unveil the company’s ambitious designs and the perils that lie in wait. We shall weigh the risks, and determine if the potential rewards are sufficient to justify braving the tempest. For in the world of finance, as in the theatre, one must be prepared for both applause and rotten tomatoes.

The presiding figure, Mr. Musk, is a subject of considerable speculation. His history is populated with pronouncements and achievements that defy conventional forecasting. To wager against him, it is often noted, is to invite a peculiar form of financial disappointment, though one suspects the precise nature of this disappointment is rarely fully understood until it manifests itself. The logic of his successes remains opaque, a series of improbable outcomes achieved through means that seem to operate outside the established parameters of industrial efficiency.

Because today? Today, it’s bouncing back. A pathetic, desperate little bounce, but a bounce nonetheless. 4% as of late morning. A band-aid on a gaping wound, sure, but in this business, you take what you can get. It’s like watching a wounded beast try to stand. You almost want it to make it. Almost.

UnitedHealth. UnitedHealth! Down 20%. Twenty percent! Because of… earnings. Earnings! It’s always earnings. They can’t just have earnings, can they? They have to disappoint with earnings. And of course, it drags down the whole healthcare sector, and then the Dow feels the need to suffer. It’s a domino effect of… competence failure. And you know what? It’s irritating. Micron and Amazon are up, though. Because AI. Everything’s “AI” now. Like that solves everything. Amazon’s ditching its Fresh and Go stores. Switching to Whole Foods. “Expanding grocery delivery.” It’s just… rearranging deck chairs on the Titanic, isn’t it?

Trading volume reached a rather robust 60.8 million shares, which is approximately 76% above its three-month average of 34.5 million. That’s a lot of shares. Enough shares, in fact, to build a small, moderately priced moon base. (Okay, that’s an exaggeration. But it is a lot of shares.) Bradesco IPO’d in 2002 and has experienced a growth of 387% since then. Which, when you consider the sheer randomness of the stock market, is rather less improbable than, say, a penguin learning to play the ukulele.

The year past saw its shares tumble some 42%, a precipitous descent that might have disheartened a less…optimistic investor. However, 2026 has begun with a modest ascent of nearly 6%. A pittance, perhaps, in the grand scheme, but as the playwrights of old were wont to say, every journey begins with a single step, or in this case, a fractional gain.

One wonders if the shareholders’ enthusiasm is entirely warranted, or merely a fleeting fancy. The scent of possibility, after all, can be quite intoxicating, especially when one has lingered too long in the shadows of stagnation. But let us not rush to judgment. The landscape of technological production is rarely as simple as it appears.

Eight percent growth in the final quarter, a mere two percent organically… a trifle, one might think. Yet, it was enough to provoke the wrath of Wall Street, to send tremors through the carefully constructed edifice of investor confidence. The stock, already burdened by the anxieties of the past year, has now fallen roughly thirty percent. It is a humbling spectacle, a reminder that even the most promising enterprises are not immune to the capricious winds of fortune.